2021 | SU BioMedicine conducted the EU notification of a food supplement for Defender-YPF and successfully obtained KAG-nr. and PL nr.
2021 | SU BioMedicine supported Tasly Group to successfully complete the EU registration of the Xiao Yao tablet product according to tHMP (traditional Herbal medicinal product) in the Netherlands.
2020 | SU BioMedicine assisted HuaSun Pharmaceutical Group to promote the Refined Notoginseng Root Dry Extract entering German pharmacopeia (DAB) monograph.
2019 | International Forum on Traditional Chinese Medicine and Botanical Medicine in Shenzhen, China: For more information, please visit http://www.tcmbif.com
2018 | SU BioMedicine assisted HuaSun Pharmaceutical Group to promote the Refined Notoginseng Root Dry Extract entering Deutscher Arzneimittel-Codex (DAC) monograph.
2017 | XIX Pharmaceutical Congress of São Paulo, Brazil
2017 | Traditional Medicine International Cooperation Forum (2017 TMIF), Macao, China
2012 | SU BioMedicine’s project with Diao was chosen as one of the 10 most scientific innovative achievements by the Chinese Academy of Sciences, Chinese Academy of Engineering, the Ministry of Science and Technology and the Nature Science foundation.